RESUMO
Objective: To systematically evaluate the efficacy of acupuncture in the treatment of schizophrenia. Methods: We searched China National Knowledge Infrastructure (CNKI), Wanfang Database, Chongqing VIP Chinese Science and Technology Periodical Database (VIP), China Biology Medicine Database (CBM), PubMed, Embase, Web of Science, Cochrane Library for relevant literature on the acupuncture treatment of schizophrenia published from database inception to May 17, 2023. The evaluation criteria included total effective rate, incidence of adverse reactions, TESS scale, PANSS scale, BPRS scale, SANA scale, SAPS scale. Two researchers independently screened the literature, extracted data, and assessed the risk of bias of the included studies. The RevMan 5.4 software was used for meta-analysis, risk of bias (ROB) evaluation tool was used to evaluate the risk of bias of the studies, and the GRADE evaluation tool was used to evaluate the quality of evidence. The study was registered on PROSPERO, CRD42023416438. Results: A total of 38 RCTs involving 3143 patients were included in the meta-analysis. The results showed that acupuncture can improve the total effective rate [OR=3.43 (95% CI: 2.71, 4.35), moderate credibility], reduce the incidence of adverse reactions [OR=0.45 (95% CI: 0.32, 0.63), moderate credibility], reduce the TESS score (side effect scale) [MD=-1.83 (95% CI: -2.94, -0.71), very low credibility]. Acupuncture also reduced the PANSS total score [MD=-5.75 (95% CI: -8.08, -3.42), very low credibility], SANA score [MD=-2.66 (95% CI: -6.84, 1.51), very low credibility], SAPS score [MD=-1.26 (95% CI: -2.55, -0.02), very low credibility], and BPRS score [MD=-7.02 (95% CI: -10.59, -3.46), very low credibility]. Conclusion: Existing evidence indicates that acupuncture as an adjunctive therapy can improve the total effective rate of SZ patients, reduce the incidence of adverse reactions, improve clinical symptoms, and alleviate depression and anxiety in SZ patients. However, more high-quality clinical research evidence is still needed to support these findings.
RESUMO
Pronounced absorption in the visible-NIR range of 400-1300 nm is demonstrated in the Ag(2)S nanoparticles (NPs)/ZnO nanowire (NW) array. ZnO NW arrays are grown on indium tin oxide substrates using chemical bath deposition. The Ag(2)S NPs are sequentially formed on the ZnO NWs through sonochemical synthesis. Structural characterizations indicate the slight deconstruction of surface of ZnO NWs during Ag(2)S NPs formation. By employing polysulfide electrolyte, short-circuit current (J(sc)), open-circuit voltage and therefore the efficiency of the Ag(2)S NP-sensitized ZnO NW solar cell are improved with increasing the initial sulfur concentration in the sulfur-polysulfide electrolyte. The Ag(2)S NP-sensitized ZnO NW solar cell shows a conversion efficiency of 0.49% with a superior J(sc) of ~13.7 mA cm(-2) under AM 1.5 illumination at 100 mW cm(-2). Incident photon conversion efficiency measurements reveal that Ag(2)S NPs contribute to 33.4% and 65.2% of J(sc) in the wavelength ranges of 400-700 nm and 700-1300 nm, respectively.
